Luxembourg Ministry of Health eHealth Service Platform Study

Luxembourg Ministry of Health eHealth Service Platform Study
This report analyses the opportunities for Luxembourg to implement an interoperability platform for electronic health services and provides recommendations for this platform as well as for related preliminary decisions to be taken. In 2006, the Government Council of Luxembourg approved a national eHealth plan which was developed by a working group of stakeholders in the healthcare sector in Luxembourg. This national eHealth plan recommended a number of measures with regard to interoperability such as the implementation of a common telematic platform to support sharing and exchange of medical information but also a number of healthcare specific applications.

The national eHealth plan already pointed out that interoperability is a major challenge, as well as organisational challenges. However, the national eHealth plan was still too high-level, without a clearly defined and realistic implementation scenario. In particular, a specific interoperability roadmap was missing. Hence, this roadmap and the related interoperability platform have become a priority.

As the Ministry of Health of Luxembourg wishes to define the optimal way to move forward in the national eHealth programme, PwC has been requested to conduct a study on the costs and benefits of an interoperability platform for Luxembourg. This study comprises a comparative analysis of eHealth services in other countries and transposes the results - where applicable - to the Luxembourg healthcare context.

Download: Luxembourg Ministry of Health eHealth Service Platform Study (.pdf, 4.810 KB).

Download from eHealthNews.eu Portal's mirror: Luxembourg Ministry of Health eHealth Service Platform Study (.pdf, 4.810 KB).

Most Popular Now

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...